Hair growth stimulators and inhibitors

Journal of Applied Cosmetology

Volumn 25, Issue 2, 2007, Pages 59-74

  Krus, Stanislaw ^a   Pytkowska, Katarzyna ^a   Arct, Jacek ^a,b  

^a Academy of Cosmetics and Health Care   (Poland)

^b WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Alopecia areata; Androgenetic alopecia; Hair growth cycle; Hair growth inhibitors; Hair growth promoters; Hirsutism; Telogen effluvium

Indexed keywords

AMINEXIL; ANTICOAGULANT AGENT; ANTIFIBROTIC AGENT; ANTILIPEMIC AGENT; ASIASARI RADIX EXTRACT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOWMAN BIRK INHIBITOR; CORTICOSTEROID; CYPROTERONE ACETATE; DITHRANOL; EFLORNITHINE; FINASTERIDE; FLUTAMIDE; GLUCOCORTICOID; GLYCYRRHIZA GLABRA EXTRACT; MINOXIDIL; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PLACEBO; PLANT EXTRACT; PROGESTERONE; SABAL EXTRACT; SOPHORA FLAVESCENS EXTRACT; SOYBEAN TRYPSIN INHIBITOR; SPIRONOLACTONE; SQUARIC ACID DIBUTYL ESTER; THUJAE OCCIDENTALIS EXTRACT; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ALOPECIA; ALOPECIA AREATA; ANEMIA; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONGENITAL MALFORMATION; DEPIGMENTATION; DIARRHEA; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRY SKIN; ERECTILE DYSFUNCTION; ERYTHEMA; FLUID RETENTION; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; GYNECOMASTIA; HAIR FOLLICLE; HAIR GROWTH; HAIR LOSS; HAIR ROOT; HIRSUTISM; HUMAN; HYPERKALEMIA; HYPERTRICHOSIS; LEUKOPENIA; LIBIDO; LIVER FAILURE; LIVER TOXICITY; LYMPHOCYTE; MALE TYPE ALOPECIA; NONHUMAN; OVARY DISEASE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PRURITUS; SCALING; SIDE EFFECT; SKIN DISEASE; SKIN IRRITATION; SKIN REDNESS; TACHYCARDIA; TELOGEN EFFLUVIUM;

EID: 34250020504     PISSN: 03928543     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Jones LN. (2001) Hair structure anatomy and comparative anatomy. Dermatol.Clinic. 19: 95-103.
2. Cotsarelis G, Millar SE. (2001) Towards a molecular understanding of hair loss and its treatments. Trends Mol Med 7(7):293-301.
3. Paus R, Foitzik K. (2004) In search of the "hair cycle clock": a guided tour. Differentiation 72: 489-511.
4. Krause K, Foitzik K. (2006) Biology of the Hair Follicle: The Basics. Seminar Cutan Med. Surg. 25: 2-10.
5. Jahoda CA. (2003) Cell movement in the hair follicle dermis-more than a two-way street? J. Invest. Dermatol. 121: 1267-1275.
6. Sawaya ME. (2001) Regulation of the Human Hair Cycle. Curr. Probl. Dermatol. May/June 2001
7. Stenn KS, Paus R. (2001) Controls of Hair Follicle Cycling. Physiol. Rev. 81(1): 449-494.
8. Johnson DH. (1997) Hair and Hair Care. Cosmetic Science and Technology. Marcel Dekker, New York.
9. Robbins CR. (2002) Chemical and physical behavior of human hair. 4th ed. Springer-Verlag, New York.
10. Shmidt-Ulrich R, Paus R. (2005) Molecular principles of hair follicle induction and morphogenesis. Bioessays 27: 247-261.
11. Millar SE. (2002) Molecular mechanisms regulating hair follicle development. J. Invest. Dermatol. 118(2): 216-224.
12. Peters EMJ, Hansen MG, Overall RW, et al. (2005) Control of human hair growth by neurotrophins: brain-derived neurotrophic factor inhibits hair shaft elongation, induces catagen, and stimulates follicular transforming growth factor (32 expression. J. Invest. Dermatol. 124: 675-685.
13. Foitzik K, Krause K, Nixon AJ, et al. (2003) Prolactin and Its Receptor Are Expressed in Murine Hair Follicle Epithelium, Show Hair Cycle-Dependent Expression, and Induce Catagen. Am. J. Pathol. 162: 1611-1621.
14. Sakai Y, Demay MB. (2000) Evaluation of keratinocytes proliferation and differentiation in vitamin D receptor knockout mice. Endocrinol. 141: 2043-2049.
15. Paus R. Cotsarelis G. (1999) The biology of hair follicles. N. Eng. J. Med. 341: 491-497.
16. Sinclair RD, Dawber RPR. (2001) Androgenetic alopecia in men and women. Dermatol. Clinic. 19: 167-178.
17. Kaufman KD. (2002) Androgens and alopecia. Mol. Cell. Endocrinol. 198: 89-95.
18. Rebora A. (2004) Pathogenesis of androgenetic alopecia. J. Am. Acad. Dermatol. 50(5): 777-779.
19. Hoffman R. (2002) Male androgenetic alopecia. Clinc. Exper. Dermatol. 27: 377-386.
20. Sawaya ME. (1998) Novel agents for the treatment of alopecia. Semin. Cutan. Med. Surg. 117(4): 276-283.
21. Kaufman K. (1996) Androgen metabolism as it affects hair growth in an androgenetic alopecia. Dermatol. Clin. 14: 697-711.
22. Inui S, Fukuzato Y, Nakajima T, Yoshikawa K, Itami S. (2003) Identification of androgen-inducible TGF-β1 derived from dermal papilla cells as a key mediator in androgenetic alopecia. J. Invest. Dermatol. Symp. Proceed. 8: 69-71.
23. Lachgar S, Moukadiri H, Jonca F, et al. (1996) Vascular endothelial growth factor is an autocrine growth factor of hair dermal papilla cells. J. Invest. Dermatol. 106: 17-23.
24. Birch MP, Lalla SC, Messenger AG. (2002) Female pattern hair loss. Clinc. Exper. Dermatol. 27: 387-392.
25. Trüeb RM. (2002) Molecular mechanisms of androgenetic alopecia. Exp. Gerentol. 37: 981-990.
26. Sawaya ME, Shapiro J. (2000) Alopecia: Unapproved treatments or indications. Dermatol. Clin. 18(2): 177-186.
27. Abramowicz M. (1998) Propecia and regaine extra strength for alopecia. Medical Letter, 40: 25-27.
28. Rittmaster RS .(1994) Finasteride. N. Eng. J. Med. 330: 120-125.
29. Kaufman KD, Olsen EA, Whiting DA, et al. (1998) Finasteride in the treatment of men with androgenetic alopecia. J. Am. Acad. Dermatol. 39: 578-589.
30. Leyden J, Dunlap F, Miller B, et al. (1999) Finasteride in the treatment of men with frontal male pattern hair loss. J. Am. Acad. Dermatol. 40: 930-937.
31. Price VH. (1999) Treatments of hair loss. N. Eng. J. Med. 341(13): 964-973.
32. Hordinsky MK. (2006) Treatment of noncicatrical alopecia. Seminar. Cutan. Med. Surg. 25: 51-55.
33. Han JH, Kwon OS, Chung JH, et al. (2004) Effect of minoxidil on proliferation and aptosis in dermal papilla cells of human hair follicle. J. Dermatol. Sci. 34: 91-98.
34. Sawaya ME. (1997) Clinical updates in hair. Adv. Clin. Res. Dermatol. Clin. 15: 37-43.
35. Simpson N. (1989) The management of androgenetic alopecia in women. J. Dermatol. Treat. 1: 107-112.
36. Mahé ZF. (1998) Inflammatory perifolliuclar fibrosis and alopecia. Int. J. Dermatol. 37: 416-417.
37. Park W-s, Lee C-h, Lee B-g, Chang I-s. (2003) The extract of thujae occidentalis semen inhibited 5α-reductase and androchrongenetic alopecia of B6CBAF1/j hybrid mouse. J. Dermatol. Sci. 31: 91-98.
38. Rho S-S, Park S-J, Hwang S-L, et al. (2005) The hair growth promoting effect of asiasari radix extract and its molecular regulation. J. Dermatol. Sci. 38: 89-97.
39. Kuroyanagi M, Arakawa T, Hirayama Y, Hayashi T. (1999) Antibacterial and antiandrogen flavonoids from Sophora flavescens. J. Nat .Prod. 62: 1595-1599.
40. Roh S-S, Kim ChD, Lee I-H, et al. (2002) The hair growth promoting effect of sophora flavescens extract and its molecular regulation. J. Dermatol. Sci. 30: 43-49.
41. Saw Palmetto (Serenoa respens) and One of its constituent sterol beta-sitosterol. NTP materials, available at: http://ntp.niehs.gov, August 2006
42. Negri-Cesi P, Colciago A, Poletti A, Motta M. (1999) 5α-reductase isoenzymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3. Prostate 41: 224-232.
43. Wilt TJ, MacDonald R, Ishani A. (1999) β-sitosterol fro the treatment of benign prostatic hyperplasia: a systemic review. B. J. Urol. 83: 976-983.
44. Prager N, Bickett K, French N, Marcovici G. (2002) A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5ar in the treatment of androgenetic alopecia. J. Alter. Compl. Med. 8: 143-152.
45. Iehle C, Delos S, Guirou O, et al. (1995) Human prostatic steroid 5α-reductase isoforms - A comparative study of selective inhibitors, J. Steroid Biochem. Mol. Biol. 54: 273-279.
46. McDonagh AJG, Messenger AG. (2001) Alopecia areata, Dermatol. Clinic. 19: 141-147.
47. Duvic M, Nelson A, de Andrade M. (2001) The genetics of alopecia areata. Dermatol. Clinic. 19: 135-139.
48. Gilhar A, Krueger GG. (1998) Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J. Clin. Invest. 101: 62-67.
49. Freyschmidt-Paul P, Happle R, McElwee KJ, Hoffmann R. (2003) Alopecia Areata: Treatment of Today and Tomorrow. J. Invest. Dermatol. Symp. Proceed. 8: 12-17.
50. Sawaya ME, Hordinsky MK. (1995) Glucocorticoid regulation of hair growth in alopecia areata. J. Invest. Dermatol. 104(Supl): 30S.
51. Batiuk L. (2006) Medicinal herbs in alopecia areata treatment. Glycyrrhiza glabra (In Russian), Kosmetika & Medicina, 1: 44-48.
52. Shapiro J, Price VH. (1998) Hair regrowth: therapeutic agents. Dermatol. Clin. 16: 341-356.
53. Harrison S, Sinclair R. (2002) Telogen effluvium. Clinc. Exper. Dermatol. 27: 393-399.
54. Headington J. (1993) Telogen effluvium, new concepts and review, Arch. Dermatol. 129: 356-363.
55. Nikolaou D, Gilling-Smith C. (2005) Hirsutism. Curr. Obstetr. Gynaecol. 15: 174-182.
56. Kurtis B, Brenner S. (2004) Targeting hirsutism: a new approach. Sex. Repr. Men. 2: 101-107.
57. Rittmaster RS. (1997) Hirsutism. Lancet 349: 191-195.
58. Moghetti P, Tosi F, Tosti A, et al. (2000) Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial. J. Clinic. Endocrinol. Met. 85: 89-94.
59. Lanigan SW. (2001) Management of unwanted hair in females, Clinc. Exper. Dermatol. 26: 644-647.
60. Ramos-Silva M, Ribeiro MC, Carneiro LV. (2001) Hair removal, Dermatol. Clinic. 19: 437-444.
61. Seiberg M, Liu J-C, Babiarz L, Sharlow E, Shapiro S. (2001) Soymilk reduces hair growth and hair follicle dimensions, Exp. Dermatol. 10: 405-413.
62. Paus R, Cotsarelis G. (1999) The biology of hair follicles, N. Eng. J. Med. 341: 491-497.